News by subject: HEALTH

Reunion Neuroscience Inc. ("Reunion" or the "Company"), a leader in novel psychedelic drug development committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds, today...

Highlights: The safe supply of psychedelic drug products manufactured at a GMP-level is critical in treating serious mental health issues. Minister of Mental Health and Addictions, the Honourable Carolyn Bennett, has publicly stated that safe drug...

Peel Regional Police Service (PRP) and TELUS have announced the signing of a Memorandum of Understanding (MOU) to advance 5G innovation and deploy technologies that will keep our communities safe. This association will support mission critical...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on the Company's U.S. Food & Drug...

In Canada, the vast majority of COVID-19 cases in the 0 to 18 age group have been mild or asymptomatic. This fact, combined with the reduction in routine COVID-19 laboratory testing across most of the country, means that the infection rates in...

URAC joins leaders to announce the Mental Health at Work Index, the first-of-its-kind comprehensive strategy to measure, improve and innovate workplace mental health.  URAC is a partner in the Founding Corporate Council to support the development...

Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced an update on its actively enrolling...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces the pricing of an underwritten public offering of: (i)...

Kane Biotech Inc. (the "Company" or "Kane Biotech") today announces that it has received an additional $425,000 USD of funding for its DispersinB Hydrogel® related to its Medical Technology Enterprise Consortium Research Project Award which was...

MCI Onehealth Technologies Inc. ("MCI") , a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, and Khure Health, an MCI wholly-owned subsidiary that provides artificial intelligence-based patient...

Blue-Zone Technologies, Ltd. (Blue-Zone), www.blue-zone.com, the world's first Clean-Tech Pharmaceutical company focused on the sustainable capture and recovery of waste anesthetic gasses, resulting in the production of branded generic anesthetics,...

Tryp Therapeutics, Inc.  ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that the World Intellectual Property Organization...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused...

Veteran public health leader Anuradha Gupta, who has spearheaded a host of successful global initiatives to improve the health of women and children and boost vaccine access and uptake, has joined Sabin Vaccine Institute as President of Global...

This weekend, the team at Adventure Vision will be celebrating their grand opening in Commerce City with a day of free vision care for kids in need in partnership with Von's Vision, the charity founded by Denver Broncos football legend and current...

Biogen Inc. announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BIIB800, a biosimilar candidate referencing RoACTEMRA®1 (tocilizumab), an anti-interleukin-6 receptor monoclonal antibody....

September 30, 2022 Amsterdam, the Netherlands ? Royal Philips announced that today's Extraordinary General Meeting of Shareholders (EGM) appointed Roy Jakobs as the company's next President and Chief Executive Officer, effective October 15, 2022,...

Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present...

Theralase® Technologies Inc. ("Theralase" or "Company") , a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations intended to safely...

Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today that they opened an office in...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced that, following a Type A meeting with the U.S. Food and Drug Administration...

Grow Up Conference and Expo ("Grow Up") has completed its sixth annual event based in Niagara Falls, this year being held from Sunday, September 11th until Tuesday, September 13th. Grow Up provided a 2-day conference schedule, a collaborative B2B...

Silent, possibly deadly, ever increasing and unknowingly present in over 10 million Canadians, is the liver disease known as NAFLD, now a Canadian epidemic. NAFLD, (non-alcoholic fatty liver disease) is the accumulation of fat in the liver. Risk...

Rakovina Therapeutics Inc. ("the Company"), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce two upcoming conference presentations. The 34th...

Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopar's...

Resverlogix Corp. ("Resverlogix" or the "Company") today announced that apabetalone's future clinical development related to COVID-19 will focus on the prevention and treatment of Post COVID-19 Conditions (PCC), colloquially known as long-COVID, as...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on the Company's U.S. Food & Drug...

BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce filing of a PCT patent application along...

Entourage Health Corp.  ("Entourage" or the...

Conagen announced the commercialization of its 99% high-purity salidroside made by bioconversion technology, an active ingredient from the herbal plant Rhodiola rosea (golden root). Its strong antioxidant properties as an adaptogen are associated...

The Canadian Centre on Substance Use and Addiction (CCSA) welcomes the planned federal cannabis review and looks forward to opportunities to contribute evidence on public health, public safety and equity. This evidence is based on research by our...

Tryp Therapeutics, Inc. ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced the filing of two new provisional patent applications....

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform designed to restore innate immune function, is pleased to announce it has received Health Canada clearance...

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced that updated results from the TACT...

Dr. Pang Yiu-kai, Chairman of the Hong Kong Tourism Board (HKTB), welcomed the Government's announcement on September 23 (HKT) on the new "0+3" arrangements from September 26 for inbound travellers from overseas and Taiwan through Hong Kong...

The RTOERO Foundation is now accepting letters of intent for grants of $10,000 to $50,000 to support projects that aim to improve seniors' health and wellness, promote social engagement for older adults and/or pursue innovative research in the field...

Titan Medical Inc. , a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the publication of international patent application...

Optimi Health Corp. (FRA: 8BN) ("Optimi" or the "Company"), a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and other psychedelic substances, most notably MDMA, is pleased to announce that...

Medicenna Therapeutics Corp. ("Medicenna" or "the...

Tilray Brands, Inc. ("Tilray" or the "Company") , a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that FL Group S.R.L. ("FL Group"), a division of Tilray Medical in...

FOUR20 announces the opening of its first Ontario location with the retail store based in Kitchener, a city in southeastern Ontario. The opening is the first step in FOUR20's expansion into the Ontario market with a focus on providing accessible...

The BC Cancer Foundation has today announced the launch of the historic $500 million Beyond Belief fundraising campaign to advance cancer research and enhance care across British Columbia. In...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome's Chief Executive Officer, will...

Fennec Pharmaceuticals Inc. , a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved PEDMARK® (sodium thiosulfate injection) to reduce the risk of...

Aurora Spine Corporation ("Aurora Spine" or the "Company") , a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the Lytham Partners Fall 2022 Investor...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the...

via InvestorWire -- Following a three-year hiatus, Lift&Co. Expo will return to Vancouver Convention Centre on January 12-14, 2023. The upcoming British Columbia dates are the first on the west coast for Canada's number-one cannabis conference and...

Next Generation Manufacturing Canada (NGen), the industry-led organization behind Canada's Global Innovation Cluster for Advanced Manufacturing, has announced a $10.5 million contribution to a $34.8 million project led by OmniaBio Inc. (Hamilton) and...

Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of target enrollment (948 patients). The independent...

AVRICORE HEALTH INC. (the "Company" or "AVCR") was honoured to join the Globe and Mail's recent Health Care Innovation event, featuring leaders from various corners of the sector, including Company CEO, Hector Bremner. "With about 40% of patients...